DEKK-TEC, INC.
DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre-cancerous lesions, and women's health issues. We have previously licensed two of our pipeline products to Biotech/Pharmaceutical companies who have successfully driven these compounds into Phase II clinical development. We also have experience with 510K devise submissions. Our present objective is to continue to create and develop new and novel drugs based on our current novel cancer therapeutic agents - DM-CHOC-PEN and hydroperoxy analogs.
DEKK-TEC, INC.
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
1983-01-01
Address:
New Orleans, Louisiana, United States
Country:
United States
Website Url:
http://www.dekk-tec.com
Status:
Active
Technology used in webpage:
SPF WordPress Apache Microsoft Exchange Online Office 365 Mail ReCAPTCHA PHP GoDaddy DNS PHP 7 GoDaddy
Similar Organizations
Oxford Vacmedix
Develop therapeutic agents for the treatment of cancer .
PACT
PACT develops antibody drugs for the treatment of pet cancer.
TVAX Biomedical
TVAX Biomedical develops cell-based immunotherapy for the treatment of cancer.
Official Site Inspections
http://www.dekk-tec.com Semrush global rank: 6.06 M Semrush visits lastest month: 1.35 K
- Host name: 141.40.180.107.host.secureserver.net
- IP address: 107.180.40.141
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "DEKK-TEC, Inc."
DEKK-TEC, INC.
DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre …See details»
DEKK-TEC, Inc. - Crunchbase Company Profile & Funding
DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for …See details»
Management — DEKK-TEC, INC.
DEKK-TEC, INC., Dir. Regulatory Affairs & Analytical Research, 1990 – present Imperial Division of Carboline, New Orleans, LA, Process and Development Chemist 1984 – 1985 Selected …See details»
Dekk-tec Company Profile | Management and Employees List
Dekk-tec Profile and History. DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for …See details»
Company Information - RocketReach
DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre …See details»
Organization | DEKK-TEC, Inc.
DEKK-TEC, Inc. Report issue. For profit Phase 1 Phase 2. Founded: New Orleans LA United States (1983 ... Organization Overview. First Clinical Trial. 1999 NCT00002153. First …See details»
DEKK-TEC Company Profile 2024: Valuation, Funding
DEKK-TEC General Information Description. Developer of novel drugs and devices for the management of cancer. The comapny develops therapies and clinical development candidates for the treatment of cancer, pre-cancerous …See details»
DEKK-TEC, INC. Company Profile | New Orleans, LA | Competitors ...
Find company research, competitor information, contact details & financial data for DEKK-TEC, INC. of New Orleans, LA. Get the latest business insights from Dun & Bradstreet.See details»
Company Profile Key Value Drivers - grants.nih.gov
DEKK-TEC was formed in 1983, and has utilized government and private funding to effectively develop new therapies and clinical development candidates for the treatment of cancer, pre …See details»
DEKK-TEC Company Profile - Office Locations, Competitors ... - Craft
DEKK-TEC Summary. Company Summary. Overview. DEKK-TEC is a company that provides biotechnology solutions. It develops therapies and clinical development candidates for the …See details»
Dekk-tec - Overview, News & Similar companies | ZoomInfo.com
Dekk-tec contact info: Phone number: (504) 583-6135 Website: www.dekk-tec.com What does Dekk-tec do? DEKK-TEC was formed in 1983, and has utilized government and private …See details»
DEKK-TEC, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Literatures (Medical) associated with DEKK-TEC, Inc. 15 Jun 2022 · Cancer Research Abstract CT158: Use of 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) as …See details»
Contact | Dekk-Tec
To learn more about DEKK-TEC, Inc. and its interests in adolescents and young adults (AYA) with malignancies – especially involving the brain and central nervous system components, please …See details»
DEKK-TEC, INC. - VentureRadar
Dec 31, 2018 Amount: $240,368.00 | 4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS MalignanciesSee details»
DEKK-TEC Inc. - BioCentury Company Profiles - BCIQ
DEKK-TEC Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Nextsource | Company Profile | DEKK-TEC, Inc.
See how DEKK-TEC, Inc. is performing against competitors in their latest market positioning. Find out if DEKK-TEC, Inc. is undergoing leadership changes or executive team restructuring. Get …See details»
Business Profile for Dekk Tec Inc - Better Business Bureau
Business Profile for Dekk Tec Inc. Pharmaceutical Research. At-a-glance. Contact Information. 725 Topaz Street. New Orleans, LA 70124. Visit Website (504) 583-6135. Customer Reviews. …See details»
DEKK-TEC CEO and Key Executive Team | Craft.co
DEKK-TEC's CEO is Lee Roy Morgan. DEKK-TEC's key executives include Lee Roy Morgan and 1 others. Lee Roy Morgan. CEO. Andrew H. Rodgers. Director of Regulatory Affairs. Report …See details»
DEKK-TEC, Inc. - Tech Stack, Apps, Patents & Trademarks
DEKK-TEC, Inc. is actively using 3 technologies for its website, according to BuiltWith. These include U.S. Server Location, WordPress, and WordPress 3.2. UNLOCK PREMIUM DATA …See details»
Lee Roy Morgan Jr., MD, PhD Active Member AACR Member Since …
Career in experimental/clinical oncology and organize an R & D company (DEKK-TEC, Inc.) that ... AACR continues to be an educational organization with media coverage that extracts and …See details»